Clinical RoundupFree Half of prostate cancer focal therapy use falls outside current guideline-supported patient groups, study finds August 14, 2026Vol.52 No.32
Clinical RoundupFree HCC-LIVE consortium publishes treatment framework for hepatocellular carcinoma August 14, 2026Vol.52 No.32
Clinical RoundupFree Baylor researchers develop drug aimed at overcoming cancer drug resistance August 14, 2026Vol.52 No.32
Clinical RoundupFree SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA advisory committee to vote on GRAIL’s multi-cancer detection test, Galleri August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA approves companion diagnostic supporting patients with advanced melanoma August 14, 2026Vol.52 No.32
Cancer History ProjectFree Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor July 31, 2026Vol.52 No.30By Sara Willa Ernst
FreeObituary Gary Morrow, a pioneer in supportive oncology, dies of prostate cancer complications at 82 July 24, 2026Vol.52 No.29By Leslie Orr
FreeObituary Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61 July 02, 2026Vol.52 No.26By Paul Goldberg
